BioSensics to Validate Digital Health Tech for PSP and DLB Monitoring
BioSensics is leading a study to validate wearable digital health technologies for monitoring motor function in PSP, MCI-LB, and DLB.
Therapeutic Area
Therapeutic area intelligence for Progressive Supranuclear Palsy and Dementia with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.